{
    "organizations": [],
    "uuid": "7481cf9af08eda438b4b4df26a4dc2e9b3f63557",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-seres-therapeutics-says-has-cash-c/brief-seres-therapeutics-says-has-cash-cash-equivalents-and-investments-of-171-3-mln-idUSFWN1P30LH",
    "ord_in_thread": 0,
    "title": "BRIEF-Seres Therapeutics Says Has Cash, Cash Equivalents And Investments Of $171.3 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Seres Therapeutics Inc:\n* SERES THERAPEUTICS SAYS HAS CASH, CASH EQUIVALENTS AND INVESTMENTS OF $171.3 MILLION, AS OF SEPT 30, 2017 - SEC FILING Source text: ( bit.ly/2qFSBN0 ) Further company coverage:\n ",
    "published": "2018-01-08T21:25:00.000+02:00",
    "crawled": "2018-01-09T16:51:33.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "seres",
        "therapeutic",
        "inc",
        "seres",
        "therapeutic",
        "say",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "sept",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}